{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:13:54Z","timestamp":1785896034919,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.thromres.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T11:40:03Z","timestamp":1524656403000},"page":"S89-S93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S1","title":["Management of thrombocytopenia in cancer"],"prefix":"10.1016","volume":"164","author":[{"given":"Giancarlo","family":"Castaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.02.001_bb0005","first-page":"282","article-title":"Managing thrombocytopenia associated with cancer chemotherapy","volume":"29","author":"Kuter","year":"2015","journal-title":"Oncology"},{"key":"10.1016\/j.thromres.2018.02.001_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/11594310-000000000-00000","article-title":"Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study","volume":"34","author":"Ten Berg","year":"2011","journal-title":"Drug Saf."},{"issue":"Pt2","key":"10.1016\/j.thromres.2018.02.001_bb0015","first-page":"2416","article-title":"Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of large outpatient oncology practice database","volume":"31","author":"Wu","year":"2000","journal-title":"Clin Ther 2009"},{"key":"10.1016\/j.thromres.2018.02.001_bb0020","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemis","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2018.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2018.02.001_bb0030","article-title":"Thrombo-hemorrhagic deaths in acute promyelocytic leukemia","volume":"133","author":"Breccia","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2018.02.001_bb0040","first-page":"521","volume":"14","author":"Tagariello","year":"2016","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2018.02.001_bb0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/asheducation-2015.1.462","volume":"2015","author":"Fasano","year":"2015","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.thromres.2018.02.001_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0268-960X(98)90001-7","article-title":"Diagnosis and treatment of patients refractory to platelet transfusions","volume":"12","author":"Contreras","year":"1998","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2018.02.001_bb0055","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusionplatelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion","volume":"337","author":"The Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.02.001_bb0065","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1537-2995.2012.03593.x","article-title":"Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes","volume":"52","author":"Wiita","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2018.02.001_bb0070","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Study alliance leukemia. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"TOPPS investigators. A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/cncr.28663","article-title":"Results of a randomized, double-blind study of romiplostim versus placebo in patients with low\/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia","volume":"120","author":"Giagounidis","year":"2014","journal-title":"Cancer"},{"issue":"xxx","key":"10.1016\/j.thromres.2018.02.001_bb0085","article-title":"The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors","volume":"102","author":"Al-Samkari","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2018.02.001_bb0090","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/bjh.14792","article-title":"Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy","volume":"178","author":"Fenaux","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2018.02.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00149-0","article-title":"Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1\/2 trial","volume":"2","author":"Platzbecker","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.thromres.2018.02.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2015.02.004","article-title":"Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia","volume":"43","author":"McElroy","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.thromres.2018.02.001_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cam4.326","article-title":"Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study","volume":"4","author":"Winer","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.thromres.2018.02.001_bb0110","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/cncr.28253","article-title":"Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies","volume":"119","author":"Antun","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2018.02.001_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.21958","article-title":"Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage","volume":"107","author":"Kalmadi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2018.02.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009733.pub2","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders","volume":"7","author":"Wardrop","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.thromres.2018.02.001_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness\u2014practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"8655","key":"10.1016\/j.thromres.2018.02.001_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(89)90181-5","article-title":"Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia","volume":"2","author":"Avvisati","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.02.001_bb0135","first-page":"584","article-title":"Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies","volume":"82","author":"Castaman","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2018.02.001_bb0140","first-page":"118","article-title":"Platelet transfusion and thrombosis: more questions than answers","volume":"42","author":"Schmidt","year":"2016","journal-title":"Semin Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.02.001_bb0145","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","article-title":"Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer","volume":"168","author":"Khorana","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2018.02.001_bb0150","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.02.001_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"AABB. Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann. Intern. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T09:59:03Z","timestamp":1541843943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818300628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"alternative-id":["S0049384818300628"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.02.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of thrombocytopenia in cancer","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}